Gilder Gagnon Howe & Co’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $24.1M | Sell |
|
|||||
|
2023
Q4 | $26.2M | Sell |
|
|||||
|
2023
Q3 | $25.7M | Sell |
|
|||||
|
2023
Q2 | $46.6M | Sell |
|
|||||
|
2023
Q1 | $38.2M | Sell |
|
|||||
|
2022
Q4 | $49.1M | Sell |
|
|||||
|
2022
Q3 | $57.2M | Sell |
|
|||||
|
2022
Q2 | $57.6M | Sell |
|
|||||
|
2022
Q1 | $84.3M | Sell |
|
|||||
|
2021
Q4 | $129M | Buy |
|
|||||
|
2021
Q3 | $141M | Sell |
|
|||||
|
2021
Q2 | $222M | Sell |
|
|||||
|
2021
Q1 | $172M | Sell |
|
|||||
|
2020
Q4 | $270M | Sell |
|
|||||
|
2020
Q3 | $119M | Sell |
|
|||||
|
2020
Q2 | $81.9M | Buy |
|
|||||
|
2020
Q1 | $57.1M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $14K | Sell |
|
|||||
|
2018
Q4 | $16K | Sell |
|
|||||
|
2018
Q3 | $278K | Sell |
|
|||||
|
2018
Q2 | $208K | Sell |
|
|||||
|
2018
Q1 | $269K | Sell |
|
|||||
|
2017
Q4 | $237K | Buy |
|